Related Experiment Video
Updated: Apr 6, 2026
Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
Published on: November 10, 2013
Anticancer Organometallic Osmium(II)-p-cymene Complexes
Emilia Păunescu1, Patrycja Nowak-Sliwinska1,2, Catherine M Clavel1
1Institut des Sciences et Ingénierie Chimiques, Ecole Polytechnique Fédérale de Lausanne, 1015 Lausanne (Switzerland).
New organometallic osmium(II)-p-cymene complexes show promise as anticancer drugs. These compounds selectively target cancer cells, induce apoptosis, and inhibit vascularization, suggesting potential clinical applications.
Area of Science:
- Organometallic Chemistry
- Medicinal Chemistry
- Cancer Biology
Background:
- Osmium compounds are emerging as potential anticancer agents.
- Bifunctional organometallic osmium(II)-p-cymene complexes offer a novel therapeutic avenue.
Purpose of the Study:
- To synthesize and evaluate the antiproliferative activity of novel osmium(II)-p-cymene complexes.
- To assess the selectivity and mechanism of action of promising compounds against cancer cells.
Main Methods:
- Synthesis of osmium(II)-p-cymene complexes functionalized with alkyl or perfluoroalkyl groups.
- In vitro antiproliferative assays against human ovarian carcinoma (A2780) and non-cancerous cell lines (HEK-293, ECRF24).
- Apoptosis induction studies and in vivo vascularization assays using the chicken embryo chorioallantoic membrane (CAM) model.
Main Results:
- Three osmium compounds exhibited selectivity towards cancer cells, showing moderate cytotoxicity against A2780 cells but not against HEK-293 or ECRF24 cells.
- Two of the selective compounds induced cancer cell death primarily through apoptosis.
- These two compounds also demonstrated anti-angiogenic properties by disrupting vascularization in the CAM model.
Conclusions:
- The synthesized osmium(II)-p-cymene complexes display promising anticancer properties, including cancer-cell selectivity, apoptosis induction, and anti-angiogenic effects.
- These findings highlight the potential clinical applications of these novel organometallic compounds in cancer therapy.
More Related Videos
07:20Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
09:45Accessing Valuable Ligand Supports for Transition Metals: A Modified, Intermediate Scale Preparation of 1,2,3,4,5-Pentamethylcyclopentadiene
Published on: March 20, 2017
Related Concept Videos
01:23Properties of Organometallic Compounds
02:44Oxidation of Alkenes: Syn Dihydroxylation with Osmium Tetraoxide
02:34Structural Isomerism
Isomers are different chemical species that have the same chemical formula. Structural isomerism of coordination compounds can be divided into two subcategories, the linkage isomers and coordination-sphere isomers.
Linkage isomers occur when the coordination compound contains a ligand that can bind to the transition metal center through two different atoms. For example, the CN− ligand can bind through the carbon atom or through the nitrogen atom. Similarly, SCN− can...
02:52Stereoisomerism
Isomers are different chemical species that have the same chemical formula.
Transition metal complexes often exist as geometric isomers, in which the same atoms are connected through the same types of bonds but with differences in their orientation in space. Coordination complexes with two different ligands in the cis and trans positions from a ligand of interest form isomers. For example, the octahedral [Co(NH3)4Cl2]+ ion has two isomers (Figure 1) In the cis...
02:51Metal-Ligand Bonds
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
01:46Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...